Analysis of Renal Platinum Content as a Novel Approach to Protect against Cisplatin Nephrotoxicity: A Review
Yasmen F. Mahran & Omkulthom M. Al Kamaly · Journal of Pharmaceutical Research International · 2021
Cisplatin (cis-diamine-dichloroplatinum (II), CDDP) is a prominent member of the effective broad-spectrum antitumor drugs. However, its clinical usage is restricted due to serious side effects particularly nephrotoxicity. The vulnerability of the kidney to CDDP is almost certainl...
Open access
Research Article
10.9734/jpri/2021/v33i531178